tiprankstipranks
Advertisement
Advertisement

VBIO Stock Latest News

Valion Bio Secures New Series B Preferred Financing
Company AnnouncementsValion Bio Secures New Series B Preferred Financing
9d ago
8K
VBIO
Valion Bio announces U.S. government-funded entolimod studies
PremiumThe Fly
Valion Bio announces U.S. government-funded entolimod studies
10d ago
VBIO
Valion Bio says Ukraine Ministry of Health accepts entolimod regulatory dossier
PremiumThe Fly
Valion Bio says Ukraine Ministry of Health accepts entolimod regulatory dossier
10d ago
VBIO
Valion Bio Issues Milestone Preferred Stock to Investors
PremiumCompany Announcements
Valion Bio Issues Milestone Preferred Stock to Investors
20d ago
8K
VBIO
Valion Bio’s regulatory dossier for Entolimod accepted for review in Ukraine
PremiumThe Fly
Valion Bio’s regulatory dossier for Entolimod accepted for review in Ukraine
1M ago
VBIO
Valion Bio files to sell 29.41M shares of common stock, warrants
PremiumThe FlyValion Bio files to sell 29.41M shares of common stock, warrants
1M ago
VBIO
Valion Bio advances Entolimod platform and manufacturing scale-up
Premium
Company Announcements
Valion Bio advances Entolimod platform and manufacturing scale-up
1M ago
8K
VBIO
Valion Bio reports continued development of Entolimod program
Premium
The Fly
Valion Bio reports continued development of Entolimod program
1M ago
VBIO
Valion Bio Completes New Preferred Stock Financing Round
PremiumCompany Announcements
Valion Bio Completes New Preferred Stock Financing Round
2M ago
8K
VBIO
Valion Bio Shareholders Approve Director, Auditor and Equity Plan
PremiumCompany Announcements
Valion Bio Shareholders Approve Director, Auditor and Equity Plan
3M ago
8K
VBIO
Valion Bio Reports Q1 Results, Advances Entolimod Platform
PremiumCompany Announcements
Valion Bio Reports Q1 Results, Advances Entolimod Platform
3M ago
8K
VBIO
Valion Bio’s Velocity Bioworks licenses LarmorBio’s BioScan-NMR platform
PremiumThe Fly
Valion Bio’s Velocity Bioworks licenses LarmorBio’s BioScan-NMR platform
3M ago
VBIO
Valion Bio reports Q1 EPS ($2.23) vs. ($2.52) last year
PremiumThe FlyValion Bio reports Q1 EPS ($2.23) vs. ($2.52) last year
3M ago
VBIO
Valion Bio receives first study protocol under agreement with NIAID
Premium
The Fly
Valion Bio receives first study protocol under agreement with NIAID
4M ago
VBIO
Valion Bio Appoints Melinda Lackey as General Counsel
Premium
Company Announcements
Valion Bio Appoints Melinda Lackey as General Counsel
4M ago
8K
VBIO
Valion Bio names Melinda Lackey as General Counsel
PremiumThe FlyValion Bio names Melinda Lackey as General Counsel
4M ago
TCRT
VBIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >